1. Home
  2. HQH vs DRTS Comparison

HQH vs DRTS Comparison

Compare HQH & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Healthcare Investors Shares of Beneficial Interest

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

HOLD

Current Price

$21.25

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$15.04

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQH
DRTS
Founded
1986
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HQH
DRTS
Price
$21.25
$15.04
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.67
AVG Volume (30 Days)
120.4K
★ 591.7K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
★ 11.56%
N/A
EPS Growth
N/A
N/A
EPS
★ 1.09
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$699.98
P/E Ratio
$19.52
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.14
$3.43
52 Week High
$24.85
$15.79

Technical Indicators

Market Signals
Indicator
HQH
DRTS
Relative Strength Index (RSI) 37.59 54.36
Support Level $18.73 $13.73
Resistance Level $22.29 $15.01
Average True Range (ATR) 0.41 0.64
MACD -0.07 -0.08
Stochastic Oscillator 9.87 56.28

Price Performance

Historical Comparison
HQH
DRTS

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: